Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 8

Results: 15

Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1305, doi. 10.1007/s00262-018-2190-4
By:
- Brown, Zachary J.;
- Yu, Su Jong;
- Heinrich, Bernd;
- Ma, Chi;
- Fu, Qiong;
- Sandhu, Milan;
- Agdashian, David;
- Zhang, Qianfei;
- Korangy, Firouzeh;
- Greten, Tim F.
Publication type:
Article
Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1297, doi. 10.1007/s00262-018-2189-x
By:
- Karpathiou, Georgia;
- Chauleur, Celine;
- Hathroubi, Sirine;
- Habougit, Cyril;
- Peoc’h, Michel
Publication type:
Article
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1317, doi. 10.1007/s00262-018-2191-3
By:
- Calabrò, Luana;
- Morra, Aldo;
- Cornelissen, Robin;
- Aerts, Joachim;
- Maio, Michele
Publication type:
Article
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1285, doi. 10.1007/s00262-018-2188-y
By:
- Segatori, Valeria I.;
- Cuello, Héctor A.;
- Gulino, Cynthia A.;
- Albertó, Marina;
- Venier, Cecilia;
- Guthmann, Marcelo D.;
- Demarco, Ignacio A.;
- Alonso, Daniel F.;
- Gabri, Mariano R.
Publication type:
Article
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1271, doi. 10.1007/s00262-018-2186-0
By:
- Leone, Robert D.;
- Sun, Im-Meng;
- Oh, Min-Hee;
- Sun, Im-Hong;
- Wen, Jiayu;
- Englert, Judson;
- Powell, Jonathan D.
Publication type:
Article
Longitudinal studies of the <sup>18</sup>F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1261, doi. 10.1007/s00262-018-2183-3
By:
- Sachpekidis, Christos;
- Anwar, Hoda;
- Winkler, Julia K.;
- Kopp-Schneider, Annette;
- Larribere, Lionel;
- Haberkorn, Uwe;
- Hassel, Jessica C.;
- Dimitrakopoulou-Strauss, Antonia
Publication type:
Article
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1251, doi. 10.1007/s00262-018-2181-5
By:
- Mølgaard, Kasper;
- Harwood, Seandean L.;
- Compte, Marta;
- Merino, Nekane;
- Bonet, Jaume;
- Alvarez-Cienfuegos, Ana;
- Mikkelsen, Kasper;
- Nuñez-Prado, Natalia;
- Alvarez-Mendez, Ana;
- Sanz, Laura;
- Blanco, Francisco J.;
- Alvarez-Vallina, Luis
Publication type:
Article
Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1231, doi. 10.1007/s00262-018-2180-6
By:
- Kimura, Hideki;
- Matsui, Yukiko;
- Ishikawa, Aki;
- Nakajima, Takahiro;
- Iizasa, Toshihiko
Publication type:
Article
Differential regulation of human monocytes and NK cells by antibody-opsonized tumors.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1239, doi. 10.1007/s00262-018-2179-z
By:
- Yin, Jun;
- Albers, Alex J.;
- Smith, Thomas S.;
- Riddell, Geoffrey T.;
- Richards, John O.
Publication type:
Article
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1197, doi. 10.1007/s00262-018-2178-0
By:
- Gauci, Marie-Léa;
- Boudou, Philippe;
- Baroudjian, Barouyr;
- Vidal-Trecan, Tiphaine;
- Da Meda, Laetitia;
- Madelaine-Chambrin, Isabelle;
- Basset-Seguin, Nicole;
- Bagot, Martine;
- Pages, Cécile;
- Mourah, Samia;
- Resche-Rigon, Matthieu;
- Pinel, Sylvine;
- Sassier, Marion;
- Rouby, Franck;
- Eftekhari, Pirayeh;
- Lebbé, Céleste;
- Gautier, Jean-François
Publication type:
Article
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1209, doi. 10.1007/s00262-018-2176-2
By:
- Ollier, Jocelyn;
- Kervarrec, Thibault;
- Samimi, Mahtab;
- Benlalam, Houssem;
- Aumont, Pascal;
- Vivien, Régine;
- Touzé, Antoine;
- Labarrière, Nathalie;
- Vié, Henri;
- Clémenceau, Béatrice
Publication type:
Article
Targeting myeloid-derived suppressor cells for cancer immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1181, doi. 10.1007/s00262-018-2175-3
By:
- Liu, Yijun;
- Wei, Guowei;
- Cheng, Wesley A.;
- Dong, Zhenyuan;
- Sun, Han;
- Lee, Vincent Y.;
- Cha, Soung-Chul;
- Smith, D. Lynne;
- Kwak, Larry W.;
- Qin, Hong
Publication type:
Article
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1221, doi. 10.1007/s00262-018-2174-4
By:
- Ben-Avi, Ronny;
- Farhi, Ronit;
- Ben-Nun, Alon;
- Gorodner, Marina;
- Greenberg, Eyal;
- Markel, Gal;
- Schachter, Jacob;
- Itzhaki, Orit;
- Besser, Michal J.
Publication type:
Article
Response to “Immune-mediated cholangitis: is it always nivolumab’s fault?”.
Published in:
2018
By:
- Kashima, Jumpei;
- Okuma, Yusuke
Publication type:
Letter to the Editor
Immune-mediated cholangitis: is it always nivolumab’s fault?
Published in:
2018
By:
- Gelsomino, Francesco;
- Vitale, Giovanni;
- Ardizzoni, Andrea
Publication type:
Letter to the Editor